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ABSTRACT: The monoclonal antibody M35, one of the first
monoclonal antibodies successfully raised against muscarinic
acetylcholine receptors, has been widely used to study the dis-
tribution of this protein in a variety of tissues and cell types of
different species. It is not fully known, however, to which mus-
carinic acetylcholine receptor subtypes M35 binds. Knowledge
of subtype-selectivity of M35 is a necessary step towards a func-
tional interpretation of the obtained immunocytochemical data.
The aim of the present study was to determine the subtype-se-
lectivity of M35 employing transfected CHO-K1 cells stably ex-
pressing human m1–m5 muscarinic acetylcholine receptors
separately, and to study M35 immunoreactivity in areas of rat
central and peripheral tissues known to be specifically enriched
in a single muscarinic acetylcholine receptor subtype. The re-
sults show that (a) all five transfected cell lines were immuno-
positive for M35, (b) nontransfected control cells were immu-
nonegative, (c) the number of mAChRs expressed per cell
correlated positively with the intensity of M35 immunoreactivity,
and (d) cell types in aldehyde-fixed rat tissue enriched in a single
m1–m4 subtypes revealed clear M35 immunoreactivity. Taken
together, the present results show that M35 does not discrimi-
nate between muscarinic acetylcholine receptor subtypes. Evi-
dently, the epitope of M35 on the receptor-protein is preserved
on all muscarinic acetylcholine receptor subtypes. The epitope
for M35 must, therefore, be localized on a homologous part of
each subtype. Q 1997 Elsevier Science Inc.
KEY WORDS: Pancreas, CHO-cells, Immunocytochemistry, Lo-
calization.
INTRODUCTION
An important step forward in the study of muscarinic acetylcholine
receptor (mAChR) structure and function was the development of
antibodies directed against the receptor protein. Monospecific mono-
clonal antibodies were obtained against membrane receptors to lo-
calize receptor proteins by immunocytochemistry [21,31]. The
monoclonal antibody M35 is one of the first monoclonal antibodies
successfully raised against mAChRs [2]. M35, an IgM, has several
characteristic features. It cannot be used in a Sodium Dodecyl Sul-
phate (SDS)-PAGE Western blot, suggesting that the antigenic de-
terminant(s) recognized by M35 are lost during the SDS electro-
phoresis or during the transfer to nitrocellulose [3]. M35
immunoprecipitates the active form of mAChRs [3], and partially
mimics the agonist activity of acetylcholine (ACh) on guinea pig
myometrium [18], but does not interfere with agonist or antagonist
binding to mAChRs [40]. M35 has been used as a tool to dissect
the interactions between biochemical and physiological events fol-
lowing mAChR stimulation, and to locate mAChRs in a variety of
tissues (Table 2). Various studies describe (a) mAChR distribution
at peripheral organs and cell types [5,15,18,26,30,35], (b) mAChR
distribution at the cellular and subcellular level in the rat forebrain,
[21,23,32,33,36,43,44], (c) the neurochemical nature of the M35-
positive neurons by immunofluorescence colocalization studies
[14,33,44], (d) changes during development, aging and dementia
in mAChR distribution in the brain [8,34,36,40], and (e) experi-
mentally induced plasticity in mAChR distribution [6,22,37,39].
It is not known whether M35 binds selectively to mAChR-sub-
types. Previously, pharmacological and anatomical data suggested
that it is unlikely that M35 binds to a singe subtype of mAChRs
[18,34,35], and Vasudevan and co-workers demonstrated in trans-
fected cell lines that M35 does at least recognize the m3 subtype
[41]. Knowledge of subtype selectivity of M35 is a necessary step
towards a functional interpretation of the observed plasticity in M35
immunoreactivity [6,22,37,38,39]. The aim of the present study was
to determine the mAChR subtype selectivity of M35 employing
transfected CHO-K1 cells stably expressing human m1–m5 m-
AChRs separately [7,10]. After determining the subtype selectivity,
cell types in rat central and peripheral tissues known to be specifi-




Chinese hamster ovary cell lines (CHO-K1), stably express-
ing pure populations of human m1–m5 muscarinic receptors sep-
arately [8,11], were a generous gift from Dr. M. R. Brann (Uni-
versity of Vermont) . Nontransfected CHO-K1 cells were
purchased from American Type Culture Collection (Rockville,
MD). Cells were grown at 377C in 95% humidified air /5% car-
bon dioxide, in Minimum Essential Eagle’s medium (Gibco,
Grand Island, NY) supplemented with 10% bovine serum opti-
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FIG. 1. M35 immunoreactivity in CHO-K1 cells expressing mAChR-subtype m1 (B), m2 (C), m3 (D), m4 (E), and m5
(F) separately. Nontransfected cells (A) were immunonegative.
mized for CHO cells (HyClone, Logan, MO), 100 units /ml pen-
icillin, and 100 mg/ml streptomycin. For transfected cells only,
0.1 mM gentamicin (Gibco) was included. When cells reached
80–90% confluency, they were replated on glass coverslips,
coated with 100 mg/ml poly-L-lysine (Sigma, St. Louis, MO),
and allowed to attach for 2 h.
Radioligand Binding Assay
The number of mAChRs per cell was determined by radioligand
binding assay. Confluent m1–m5 CHO cells were scraped from
culture flasks, homogenized, and sedimented. Pellets were resus-
pended in 50 mM sodium phosphate buffer (PBS) (pH 7.4), con-
taining 1 mM EDTA. Aliquots of membrane homogenates were
incubated in 1 ml of 0.1 nM 3H-N-methylscopolamine (3H-NMS)
(84 Ci/mmol, Dupont-NEN, MA) for 2 h at 257C. Membranes were
collected by filtration and radioactivity was counted as previously
described [29]. Nonspecific binding was assessed in the presence
of 1 mM quinuclidinyl benzilate. Specific 3H-NMS binding to
mAChRs was calculated as the difference between the total binding
(absence of unlabeled ligand) and nonspecific binding (excess un-
labeled ligand).
Immunocytochemical Procedure
Six adult Wistar rats (weighing 300 g) were used to study
M35 immunoreactivity in the brain and pancreas. The animals
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FIG. 2. Optical density measures of the M35 immunoreactivity in the
transfected cell lines expressing the mAChR subtypes m1–m5 sepa-
rately, as well as the control cell line K1-CHO lacking mAChRs. The
optical density is expressed in averaged percent intensity ({SEM) of
the analyzed cells as seen in Fig. 1, with 0 and 100% corresponding to
maximal levels of white and black, respectively.
TABLE 1
NUMBER OF mAChRs EXPRESSED IN
THE FIVE TRANSFECTED CELL LINES
Cell Line







Quantitation of the number of mAChRs
present per cell for the different m1–m5
CHO cell lines expressing the respective
mAChR subtype separately.
were deeply anesthetized with 6% sodium pentobarbital and
perfused transcardially with 30 ml heparinized saline (15 ml /
min) followed by 200 ml of a fixative solution composed of
2% paraformaldehyde, 0.05% glutaraldehyde and 0.2% picric
acid in 0.1 M phosphate buffer, pH 7.4 (PB) . The brain and
pancreas were removed and cryoprotected by overnight stor-
age in 30% sucrose in PB. Thereafter, immunostaining was
carried out on free-floating frozen brain sections cut coronally
and frozen sections taken from the tail of the pancreas thaw-
mounted on gelatin-coated slides. All sections were 20 mi-
crons in thickness.
The tissue sections were preincubated for 15 min in 0.1%
H2O2 in 0.01 M PBS, rinsed in PBS, and immersed in 5% normal
rabbit serum (NRS) in PBS for 30 min to reduce nonspecific
binding in the following incubation step. The sections were then
incubated with the primary antibody. M35, a monoclonal mouse
anti-mAChR IgM raised against purified bovine mAChR-protein
[2,3] , was a generous gift from Dr. A. D. Strosberg (Institut
Cochin de Genetique Mole´culaire, France) . M35 was diluted 1:5
in 2% NRS in PBS overnight at 47C under gentle movement of
the incubation medium. After the primary incubation, sections
were rinsed in PBS and again preincubated with 5% NRS for 30
min. They were then incubated with biotinylated rabbit IgG anti-
mouse-IgM (mu-chain directed, F(ab*) fraction, Zymed), di-
luted 1:200 in PBS in 2% NRS for 2 h at room temperature (RT).
Thereafter, the sections were thoroughly rinsed in PBS and in-
cubated in streptavidin-HRP (Zymed) diluted 1:200 in PBS for
2 h at RT.
CHO-K1 cells were fixed with 4% paraformaldehyde for 10
min at RT and excess fixative was rinsed off with PBS. They
were then preincubated with 10% NRS in PBS for 1 h at RT to
block nonspecific antibody binding. Excess blocking medium
was removed, and the primary antibody M35 was introduced at
a dilution of 1:5 in 2% NRS overnight at 47C. Cells were rinsed
with PBS and incubated with biotinylated rabbit IgG antimouse
IgM (mu chain directed, F(ab*) fraction, Zymed) diluted 1:200
in 2% NRS for 2 h at RT. After several rinses with PBS, endog-
enous peroxidase activity was quenched with 0.3% H2O2 in meth-
anol for 30 min. Cells were rinsed with PBS and incubated with
Vectastain Elite ABC reagent (Vector, Burlingame, CA) for 30
min at RT. The ABC reagent is a preformed avidin–biotinylated
horseradish peroxidase complex that enhances the sensitivity of
this detection method.
Finally, sections and cells were processed by the 3-3 diamino-
benzidine (DAB)-H2O2 reaction, guided by a visual control.
Once the desired staining intensity was obtained, the DAB re-
action was stopped by rinsing the brain sections in Tris HCl buf-
fer, and incubating the CHO-K1 cells with deionized water for 5
min. Control experiments were performed by omitting the pri-
mary antibody (M35) from the incubation medium for rat brain
sections and CHO-K1 cells. Coverslips were mounted on glass
microscope slides and the staining was visualized by light mi-
croscopy.
The staining intensity of M35-immunoreactivity was mea-
sured with the aid of a scanner (SigmaScan Pro image analyzer
with software by Jandel Scientific) . Individual cells were
scanned, and the average of the staining intensity of the cells per
cell line was calculated and expressed in percentage, with 0 and
100% corresponding to minimal and maximal staining possible,
respectively.
RESULTS
Binding of M35 to mAChR subtypes in transfected
CHO-K1 cells
The averaged number of mAChRs expressed per cell (Table
1) varied slightly among the different cell lines, ranging form
40,813 ({601) to 57,426 ({445). Subsequent immunostaining
with the monoclonal antibody M35 revealed that CHO-K1 cells
expressing m1 (Fig. 1B), m2 (Fig. 1C), m3 (Fig. 1D), m4 (Fig.
1E), and m5 (Fig. 1F) were all immunopositive for M35,
whereas nontransfected cells remained immunonegative (Fig.
1A). Likewise, omitting the primary antibody M35 from the in-
cubation medium yielded immunonegative results (data not
shown). The immunoprecipitate was present predominantly in
the cell cytoplasm. No gross differences were observed among
cells with different mAChR-subtypes; all cell populations were
darkly stained. The optical density measures of the M35 immu-
nostaining for the different transfected cell lines (Fig. 2) showed
that the staining of the cells was approximately four times as
high as in the control cell line, and that the staining intensity
ranked as follows: m2  m1  m3  m4  m5. This correlated
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FIG. 3. M35 immunoreactivity was found in regions known to be specifically enriched in the m1 (A), m2 (B), m3 (C) or m4 (D) mAChR
subtype. The striatum (A) contains numerous medium spiny cells (small arrows) which are moderately to strongly immunoreactive for M35.
Motorneurons in the mesencephalon (B) are heavily labeled with M35. Islets of Langerhans in the pancreas (C) contain densely stained endocrine
cells. Islands of Calleja (D) are characterized by small clusters of densely stained M35-positive neurons (small arrows). Scale bar in A, B, C,
and D  50, 20, 25, and 45 mm, respectively.
positively and significantly with the number of mAChRs ex-
pressed per cell line (r 2  0.998; p  0.0012), suggesting that
the staining intensity in transfected cells relates to the number of
mAChRs expressed, with no difference between the five sub-
types.
M35 Binding in Rat Cells Enriched in Specific
mAChR Subtypes
Cells in three brain regions and the pancreas were chosen to
study M35 binding to mAChR subtypes in situ. Medium spiny
cells in the striatum, motorneurons of the mesencephalon, en-
docrine cells of the islets of Langerhans in the pancreas, and cells
in the islands of Calleja are selectively enriched in m1, m2, m3,
and m4 mAChR subtypes, respectively [12,13,20,42]. M35 im-
munoreactivity was observed in all four areas (Fig. 3) . The stria-
tum contains numerous medium spiny cells (Fig. 3A), which
were moderately to strongly immunoreactive for M35. Besides
these neurons, large and intensely stained cells were observed
mainly in the ventrolateral aspect of the striatum. The motorneu-
rons in the mesencephalon (Fig. 3B) were heavily stained with
M35, and showed characteristic pockets of dense immunoprecip-
itate around the nucleus. Immunopositive dendritic branches
were frequently encountered among the motorneurons. The islets
of Langerhans in the pancreas contained a mixture of lightly and
densely stained endocrine cells (Fig. 3C). The densely stained
cells predominated at the periphery of the islets, whereas the
lightly stained cells were found in the core of the islets. Strongly
immunopositive fiber-like elements were occasionally observed
in the mantle of the islets. Islands of Calleja revealed small clus-
ters of darkly stained, multipolar M35-positive neurons (Fig.
3D). Like the motorneurons in the mesencephalon, these cells
have numerous immunopositive dendrites scattered throughout
the island. Qualitatively similar results were obtained using 4%
paraformaldehyde (data not shown) as used for the cell lines
instead of 2% paraformaldehyde / 0.05% glutaraldehyde as a
fixative. However, the latter fixative provides a somewhat better
signal-to-noise ratio of M35 immunoreactivity.
DISCUSSION
Comparison of M35 with other mAChR Antibodies
Recent immunological localization studies for the mAChR
subtypes m1 to m4 in rat brain have revealed that most brain
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TABLE 2
SUMMARY OF M35-BINDING TO mAChRs IN DIFFERENT SPECIES AND TISSUES*
Species Tissue Reference
cat brain [40]
chick brain E. A. Van der Zee, unpublished observations
ferret retina [15]
frog pars intermedia [16]
guinea pig brain T. Matsuyama, unpublished observations
myometrium [18]
hamster brain E. A. Van der Zee, unpublished observations
human brain [24, 32]
fibroblasts [30]




rabbit brain [9, 38]
smooth muscle [26]
rat brain [1, 23, 25, 33, 43, 44, 45]
heart E. A. Van der Zee, unpublished observations
myometrium [18]
pancreas [35]
sheep brain B. R. K. Douma, unpublished observations
vole brain E. A. Van der Zee, unpublished observations
* In addition, mAChRs were detected using M35 in sperms of a large variety of inver-
tebrate and vertebrate species by Baccetti et al. [5].
regions contain a complex mixture of mAChRs [13,19,20,27].
All cell types immunoreactive for M35 in rat brain tissue were
found to express mAChRs according to some recent studies em-
ploying mAChR subtype-selective antibodies [11,19,20,27].
However, some brain regions that are not or only weakly im-
munopositive for M35 were found to contain mAChR immuno-
reactive cells in other studies. This discrepancy may be related
to the occurrence of false negatives for M35. Experimental data
suggest that, due to the binding characteristics of M35, immu-
nostained brain tissue may contain some false negative musca-
rinic cholinoceptive neurons. For example, a significant increase
in the number of M35-positive neurons as well as a clear increase
in dendritic labeling were found after the application of 100 mM
carbachol for 15–20 min to fresh cortical brain slices. These
results suggest that some of the M35 immunonegative neurons
can be visualized by M35 after the internalization of the previ-
ously nondetectable mAChRs embedded within the cell
membrane. Possible false negatives were found by others in the
facial motorneurons and cholinergic facial nerve and olivococh-
lear bundle [45]. The possibility of false positives with M35
cannot entirely be excluded either. In a limited number of cases,
brain regions reveal high levels of M35 immunoreactivity (no-
tably in the central nucleus of the amygdala [33], and the coch-
lear root neurons [45]) , while receiving only minor cholinergic
innervation. Whether this strong immunostaining is due to cross-
reactivity, or reflects a certain physiological state of the mAChR
protein by which the epitope for M35 is maximally exposed,
remains to be determined.
Epitope Localization of M35 on the mAChR Protein
This study demonstrates that M35 recognizes all five mAChR
subtypes, and it is highly likely that these subtypes are also rec-
ognized in situ in aldehyde-fixed tissue. Evidently, the epitope
for M35 is preserved on all mAChR subtypes, as well as on the
embryonic mAChR type [17], which is biochemically different
from the adult types of mAChRs [28]. The epitope for M35
must, therefore, be localized on a part of these receptors that is
highly homologous. The exact epitope recognized by M35 is un-
known. However, biochemical data have revealed that M35 most
likely recognizes a conformational determinant only present on
the ‘‘active’’ receptor ( i.e., the nondenatured, intact mAChR pro-
tein [3,4]) . The observation that M35 can mimic some physio-
logical effects of ACh [18] suggests that it binds near or at the
ACh binding site. However, occupation of the agonist and an-
tagonist binding sites on the mAChRs by specific ligands could
not block M35 binding [40], indicating that the binding site for
M35 is not identical to the ACh binding position.
M35 binding to mAChRs has been studied in a variety of
species, tissues, and cell types (Table 2) , and to our knowledge
no species are reported in which M35 is incapable of binding to
mAChRs. This strongly suggests that the M35 epitope is pre-
served among mAChR subtypes as well as among species, and
the epitope might represent a crucial part of the functional m-
AChR protein.
In summary, the present results show that all five mAChR
subtypes (m1–m5) are recognized by M35 in transfected cells
and that at least m1–m4 are recognized in situ in rat brain or
pancreas. However, due to the immunological characteristics of
M35 and the location of its epitope on the mAChR protein, bind-
ing of M35 to mAChRs is determined by the physiological (func-
tional) state of the protein. In conclusion, the monoclonal anti-
body M35 is a very useful tool to study plastic changes in
mAChRs characteristics, whereas antibodies raised against m-
AChR peptide reveal a more static pattern of mAChR expression,
less sensitive to the prior (behavioral) history of the animal.
Combined approaches to study mAChR characteristics with M35
and subtype-specific antibodies, therefore, will provide better in-
30 J. M. CARSI–GABRENAS ET AL.
/ 2a40 2324 Mp 30 Thursday Jul 17 05:52 AM EL–BRB (v. 43, no. 6) 2324
sight in the regulation of cholinergic neurotransmission at the
level of mAChRs.
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